Nektar Therapeutics NKTR
30.20 USD -2.34 (-7.19%)
Regular-session close
30.20 0.00 0.00%
After hours · Nov 20, 4:38 PM ET
30.13 Day range 32.35
30.13 52-week range 109.00
- YTD
- -28.57%
- 1 year
- -45.20%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 55.23M | 98.43M | 90.12M | 92.06M | 101.91M | |
| 55.23M | 67.74M | 56.35M | 70.42M | 77.01M | |
| -140.10M | -105.20M | -263.68M | -376.17M | -446.10M | |
| -164.08M | -118.96M | -276.06M | -368.20M | -523.84M | |
| -9.73 | -8.68 | -21.70 | -29.50 | -42.90 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 15.12M | 44.25M | 35.28M | 88.23M | 25.22M | |
| 280.41M | 303.85M | 398.03M | 710.60M | 1.12B | |
| 190.57M | 243.11M | 267.05M | 343.96M | 437.68M | |
| 85.75M | 102.56M | 117.78M | 131.50M | 143.18M | |
| 89.83M | 60.74M | 130.99M | 366.64M | 679.51M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -208.51M | -175.71M | -192.61M | -304.01M | -412.66M | |
| -1.20M | 142.57M | 139.56M | 365.83M | 202.78M | |
| 180.57M | 42.12M | 30.00K | 1.51M | 36.24M | |
| -868.00K | 63.92M | 380.00K | 7.52M | -14.99M | |
| -29.14M | 8.97M | -52.95M | 63.01M | -173.74M |
